{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T14:46:41Z","timestamp":1772549201810,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"PACS system in Research and Development","award":["26210120004"],"award-info":[{"award-number":["26210120004"]}]},{"DOI":"10.13039\/501100008530","name":"ERDF","doi-asserted-by":"publisher","award":["26220220021"],"award-info":[{"award-number":["26220220021"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jns.2018.06.012","type":"journal-article","created":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T21:45:54Z","timestamp":1529531154000},"page":"28-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The influence of levodopa, entacapone and homocysteine on prevalence of polyneuropathy in patients with Parkinson's disease"],"prefix":"10.1016","volume":"392","author":[{"given":"Milan","family":"Grofik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0160tefan","family":"Siv\u00e1k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladim\u00edr","family":"Nos\u00e1\u013e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Tur\u010danov\u00e1 Kopru\u0161\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jozef","family":"Michalik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"\u010cierny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzana","family":"Tatarkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Egon","family":"Kur\u010da","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2018.06.012_bb0005","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/archneur.61.5.657","article-title":"Levodopa-associated increase of homocysteine levels and sural axonal neurodegeneration","volume":"61","author":"M\u00fcller","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2018.06.012_bb0010","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/mds.25585","article-title":"Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study","volume":"28","author":"Ceravolo","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2018.06.012_bb0015","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ana.22021","article-title":"Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson's disease","volume":"68","author":"Toth","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2018.06.012_bb0020","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1212\/01.WNL.0000149522.32823.EA","article-title":"Distal symmetric polyneuropathy: a definition for clinical research. Report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation","volume":"64","author":"England","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2018.06.012_bb0025","author":"Natus Neurology Training Academy"},{"key":"10.1016\/j.jns.2018.06.012_bb0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5507\/bp.2009.010","article-title":"Peripheral nerve involvement and severity of motor disorder in Parkinson's disease: a correlational study","volume":"153","author":"Chovancov\u00e1","year":"2009","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub."},{"key":"10.1016\/j.jns.2018.06.012_bb0035","first-page":"363","article-title":"Peripheral neuropathy in Parkinson's disease","volume":"36","author":"Grambalov\u00e1","year":"2015","journal-title":"Neuro. Endocrinol. Lett."},{"key":"10.1016\/j.jns.2018.06.012_bb0040","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1212\/WNL.0b013e31823a0ee4","article-title":"Neuropathy in Parkinson's disease: prevalence and determinants","volume":"77","author":"Rajabally","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2018.06.012_bb0045","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jns.2017.05.023","article-title":"Peripheral neuropathy in idiopathic Parkinson's disease: a systematic review","volume":"378","author":"Zis","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2018.06.012_bb0050","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.parkreldis.2013.09.007","article-title":"Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens","volume":"20","author":"Mancini","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2018.06.012_bb0055","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1007\/s00415-013-7079-8","article-title":"Levodopa, vitamins, ageing and the neuropathy of Parkinson's disease","volume":"260","author":"Rajabally","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2018.06.012_bb0060","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.parkreldis.2016.04.016","article-title":"Levodopa and neuropathy risk in patients with Parkinson's disease: effect of COMT inhibition","volume":"27","author":"Cossu","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2018.06.012_bb0065","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.parkreldis.2012.08.002","article-title":"Is chronic levodopa therapy associated with distal symmetric polyneuropathy in Parkinson's disease?","volume":"19","author":"Shahrizaila","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2018.06.012_bb0070","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/mds.22137","article-title":"Neuropathy as a potential complication of levodopa use in Parkinson's disease","volume":"23","author":"Toth","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2018.06.012_bb0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/mds.20261","article-title":"Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients","volume":"20","author":"Lamberti","year":"2005","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.jns.2018.06.012_bb0080","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.parkreldis.2005.01.007","article-title":"Reduced plasma homocysteine levels in levodopa\/entacapone treated Parkinson patients","volume":"11","author":"Valkovic","year":"2005","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2018.06.012_bb0085","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1034\/j.1600-0404.2003.00135.x","article-title":"Levodopa-induced hyperhomocysteinemia in Parkinson's disease","volume":"108","author":"Yasui","year":"2003","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2018.06.012_bb0090","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1212\/01.WNL.0000158674.91134.6E","article-title":"The effect of entacapone on homocysteine levels in Parkinson's disease","volume":"64","author":"Ostrem","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2018.06.012_bb0095","article-title":"Homocysteine levels in Parkinsons disease: is entacapone effective?","volume":"7563705","author":"Kocer","year":"2016","journal-title":"Biomed. Res. Int."},{"issue":"103","key":"10.1016\/j.jns.2018.06.012_bb0100","first-page":"55","article-title":"Ovlivnen\u00ed plazmatick\u00e9 hladiny homocysteinu u pacientu s Parkinsonovou chorobou terapi\u00ed L-DOPA a entacaponem","volume":"70","author":"Nevrl\u00fd","year":"2007","journal-title":"Cesk Slov Neurol N"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18302624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18302624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:44:57Z","timestamp":1758383097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X18302624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":20,"alternative-id":["S0022510X18302624"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2018.06.012","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The influence of levodopa, entacapone and homocysteine on prevalence of polyneuropathy in patients with Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2018.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}